Save information for later
Sign Up

Learn About Spastic Paraplegia Type 2

What is the definition of Spastic Paraplegia Type 2?

Spastic paraplegia type 2 is part of a group of genetic disorders known as hereditary spastic paraplegias. These disorders are characterized by progressive muscle stiffness (spasticity) and the development of paralysis of the lower limbs (paraplegia). Hereditary spastic paraplegias are divided into two types: pure and complex. The pure types involve the lower limbs. The complex types involve the lower limbs and can also affect the upper limbs to a lesser degree; the structure or functioning of the brain; and the nerves connecting the brain and spinal cord to muscles and sensory cells that detect sensations such as touch, pain, heat, and sound (the peripheral nervous system). Spastic paraplegia type 2 can occur in either the pure or complex form.

What are the causes of Spastic Paraplegia Type 2?

Mutations in the PLP1 gene cause spastic paraplegia 2. The PLP1 gene provides instructions for producing proteolipid protein 1 and a modified version (isoform) of proteolipid protein 1, called DM20. Proteolipid protein 1 and DM20 are primarily located in the brain and spinal cord (central nervous system) and are the main proteins found in myelin, the fatty covering that insulates nerve fibers. A lack of proteolipid protein 1 and DM20 can cause a reduction in the formation of myelin (dysmyelination) which can impair nervous system function, resulting in the signs and symptoms of spastic paraplegia type 2.

How prevalent is Spastic Paraplegia Type 2?

The prevalence of all hereditary spastic paraplegias combined is estimated to be 2 to 6 in 100,000 people worldwide. Spastic paraplegia type 2 likely accounts for only a small percentage of all spastic paraplegia cases.

Is Spastic Paraplegia Type 2 an inherited disorder?

This condition is inherited in an X-linked recessive pattern. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. Because females have two copies of the X chromosome, one altered copy of the gene in each cell usually leads to less severe symptoms in females than in males, or may cause no symptoms at all. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

Who are the top Spastic Paraplegia Type 2 Local Doctors?

University Of Miami

1611 Nw 12 Ave, 
Miami, FL 
 (13.7 mi)
Languages Spoken:
English, Spanish
Accepting New Patients

Gemayaret Alvarez-Gonzalez is a Physiatrist in Miami, Florida. Dr. Alvarez-Gonzalez and is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 2. Her top areas of expertise are Hemiplegia, Developmental Expressive Language Disorder, Stroke, and Spastic Diplegia Infantile Type. Dr. Alvarez-Gonzalez is currently accepting new patients.

University Of Miami

1611 Nw 12 Ave, 
Miami, FL 
 (13.7 mi)
Languages Spoken:
English, Romanian
Accepting New Patients
Offers Telehealth

Olimpia Carbunar is a Neurologist in Miami, Florida. Dr. Carbunar and is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 2. Her top areas of expertise are Inclusion Body Myositis, VEXAS Syndrome, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Benign Autosomal Dominant Myopathy. Dr. Carbunar is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More

University Of Miami

1150 Nw 14th St, 410 Pac, 
Miami, FL 
 (14.0 mi)
Languages Spoken:
English
Accepting New Patients

Michael Benatar is a Neurologist in Miami, Florida. Dr. Benatar and is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 2. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Myasthenia Gravis, Frontotemporal Dementia, and Thymectomy. Dr. Benatar is currently accepting new patients.

What are the latest Spastic Paraplegia Type 2 Clinical Trials?
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP)

Summary: The Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP) is focused on gathering longitudinal clinical data as well as biological samples (skin and/or blood and/or saliva) from male and female patients, under the age of 30, who exhibited early onset symptoms of HSP with (1) a clinical diagnosis of hereditary spastic paraplegia and (2) the presence of variants in H...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: March 01, 2008
Published By: National Institutes of Health